Cargando…
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy
Diabetic retinopathy (DR) is a universal microvascular complication of diabetes mellitus (DM), which is the main reason for global sight damage/loss in middle-aged and/or older people. Current clinical analyses, like hemoglobin A1c, possess some importance as prognostic indicators for DR severity, b...
Autores principales: | Du, Xiaohui, Yang, Le, Kong, Ling, Sun, Ye, Shen, Kunshuang, Cai, Ying, Sun, Hui, Zhang, Bo, Guo, Sifan, Zhang, Aihua, Wang, Xijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646596/ https://www.ncbi.nlm.nih.gov/pubmed/36387907 http://dx.doi.org/10.3389/fendo.2022.1037164 |
Ejemplares similares
-
Metabolomics for Biomarker Discovery: Moving to the Clinic
por: Zhang, Aihua, et al.
Publicado: (2015) -
A Hypothesis From Metabolomics Analysis of Diabetic Retinopathy: Arginine-Creatine Metabolic Pathway May Be a New Treatment Strategy for Diabetic Retinopathy
por: Sun, Ye, et al.
Publicado: (2022) -
The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy
por: Augustine, Josy, et al.
Publicado: (2021) -
The role of aldosterone in the pathogenesis of diabetic retinopathy
por: Liu, Kangcheng, et al.
Publicado: (2023) -
Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression
por: Sun, Yu, et al.
Publicado: (2021)